Iliana Chapa
Family Medicine · McAllen, TXNPI 1699304501
Payments from drug & device makers
Across 137 payments — averaging $31.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Otsuka America Pharmaceutical, Inc.$522
- Amgen$487
- Lilly USA, LLC$389
- Novo Nordisk$378
- Astellas Pharma US Inc$150
- plus $1K from 15 others
What the payments were for
- Food & beverage$4,22998%
- Education$852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $1,247 |
| Otsuka America Pharmaceutical, Inc. | 9 | $522 |
| Amgen | 8 | $487 |
| Lilly USA, LLC | 27 | $389 |
| Novo Nordisk | 23 | $378 |
| Astellas Pharma US Inc | 4 | $150 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $149 |
| AbbVie | 7 | $136 |
| Abbott | 6 | $129 |
| Boehringer Ingelheim | 6 | $122 |
| Esperion Therapeutics, Inc. | 1 | $117 |
| Integra Lifesciences Corporation | 1 | $102 |
| GSK | 5 | $90 |
| Ironwood Pharmaceuticals, Inc | 4 | $77 |
| Pfizer | 3 | $47 |
| Organon | 2 | $46 |
| Optinose US, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Lexicon Pharmaceuticals, Inc. | 1 | $26 |
| Exact Sciences | 1 | $18 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$604
- REXULTI$356
- EVENITY$275
- BREZTRI$250
- Repatha$123
- FARXIGA$122
- NEXLIZET$117
- NEXLETOL$117
- XIFAXAN$109
- Acclarent Aera$102
- Inspira Air$102
- RELIEVA SPINPLUS NAV$102
- TruDi Probe$102
How this compares
$4,314 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 59 | $95,440 |
| MounjaroTirzepatide | 24 | $44,734 |
| FarxigaDapagliflozin Propanediol | 23 | $30,433 |
| JardianceEmpagliflozin | 27 | $26,869 |
| LinzessLinaclotide | 23 | $26,489 |
| RexultiBrexpiprazole | 15 | $23,433 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $16,862 |
| SynjardyEmpagliflozin/Metformin Hcl | 15 | $15,597 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $14,345 |
| JanuviaSitagliptin Phosphate | 13 | $13,259 |
| VascepaIcosapent Ethyl | 19 | $8,827 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $1,628 |
| Pregabalin | 16 | $1,436 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 50 | $1,218 |
| Sucralfate | 30 | $1,044 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $378 | $95,44059 claims |
| Lilly USA, LLCMounjaro | $389 | $44,73424 claims |
| Boehringer IngelheimJardiance, Synjardy | $122 | $42,46642 claims |
| AstraZenecaFarxiga | $1,247 | $30,43323 claims |
| AbbVieLinzess | $136 | $26,48923 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $522 | $23,43315 claims |
| GSKTrelegy Ellipta | $90 | $16,86221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in McAllen
- Joel SolisMcAllen$21.1M
- Dimple DesaiMcAllen$3.4M
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- George AtieeSan Antonio$19.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.